2023 Q2 Form 10-Q Financial Statement

#000149315223017327 Filed on May 15, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $619.0K $1.380M $612.5K
YoY Change -17.57% 125.27% -26.9%
Cost Of Revenue $244.9K $209.0K $199.7K
YoY Change 211.58% 4.66% 19.58%
Gross Profit $374.2K $1.171M $412.8K
YoY Change -44.35% 183.6% -38.46%
Gross Profit Margin 60.44% 84.85% 67.4%
Selling, General & Admin $1.700M $1.433M $1.094M
YoY Change -21.88% 30.99% -28.45%
% of Gross Profit 454.32% 122.39% 264.98%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $165.5K $175.0K $269.9K
YoY Change -38.88% -35.15% -2.67%
% of Gross Profit 44.24% 14.95% 65.37%
Operating Expenses $1.700M $1.433M $0.00
YoY Change -21.88%
Operating Profit -$1.326M -$262.2K $412.8K
YoY Change -11.82% -163.5% -38.46%
Interest Expense $3.489M $475.7K -$1.152M
YoY Change 270.07% -141.29% 5.64%
% of Operating Profit -279.09%
Other Income/Expense, Net $1.415M -$475.7K -$1.152M
YoY Change -250.12% -58.71%
Pretax Income $89.54K -$737.9K -$1.833M
YoY Change -103.66% -59.75% -15.76%
Income Tax
% Of Pretax Income
Net Earnings $89.54K -$737.9K -$1.833M
YoY Change -103.66% -59.75% -15.76%
Net Earnings / Revenue 14.46% -53.48% -299.31%
Basic Earnings Per Share $0.00 -$0.17 -$13.75
Diluted Earnings Per Share $0.00 -$0.17 -$13.75M
COMMON SHARES
Basic Shares Outstanding 7.775M shares 3.773M shares 133.3K shares
Diluted Shares Outstanding 28.51M shares 7.308K shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $15.90K $109.0K $182.3K
YoY Change -40.22% 243.54%
Cash & Equivalents $15.90K $109.0K $182.3K
Short-Term Investments
Other Short-Term Assets $273.2K $2.880M $276.9K
YoY Change -90.08% 940.22% 2919.63%
Inventory
Prepaid Expenses
Receivables $3.147K $11.08K $243.2K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $292.2K $3.000M $702.4K
YoY Change -90.21% 327.16% 608.5%
LONG-TERM ASSETS
Property, Plant & Equipment $503.2K $457.8K $411.6K
YoY Change 64.89% 11.23% -31.18%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $45.67K $45.67K $31.44K
YoY Change 117.17% 45.26% 0.0%
Other Assets $2.726M
YoY Change
Total Long-Term Assets $3.730M $1.162M $1.483M
YoY Change 193.76% -21.63% -45.07%
TOTAL ASSETS
Total Short-Term Assets $292.2K $3.000M $702.4K
Total Long-Term Assets $3.730M $1.162M $1.483M
Total Assets $4.022M $4.162M $2.185M
YoY Change -5.48% 90.5% -21.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.370M $878.7K $230.0K
YoY Change 418.74% 282.03% 20.32%
Accrued Expenses $778.6K $553.4K $355.1K
YoY Change 747.24% 55.83% 10.53%
Deferred Revenue $1.815M $1.585M
YoY Change 20.11%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $4.989M $6.533M $3.104M
YoY Change 31.85% 110.51% 208.44%
Total Short-Term Liabilities $10.30M $10.92M $5.305M
YoY Change 60.42% 105.89% 63.94%
LONG-TERM LIABILITIES
Long-Term Debt $1.704M $1.654M $1.805M
YoY Change -7.05% -8.37% -16.19%
Other Long-Term Liabilities $515.0K $748.3K $1.254M
YoY Change -54.66% -40.34% 417.47%
Total Long-Term Liabilities $2.219M $2.402M $3.059M
YoY Change -25.26% -21.48% 27.69%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.30M $10.92M $5.305M
Total Long-Term Liabilities $2.219M $2.402M $3.059M
Total Liabilities $12.52M $13.32M $8.363M
YoY Change 33.33% 59.31% 48.52%
SHAREHOLDERS EQUITY
Retained Earnings -$52.06M -$52.15M
YoY Change 13.23%
Common Stock $59.36K $6.742K
YoY Change 6122.22%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$8.497M -$9.161M -$6.178M
YoY Change
Total Liabilities & Shareholders Equity $4.022M $4.162M $2.185M
YoY Change -5.48% 90.5% -21.91%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income $89.54K -$737.9K -$1.833M
YoY Change -103.66% -59.75% -15.76%
Depreciation, Depletion And Amortization $165.5K $175.0K $269.9K
YoY Change -38.88% -35.15% -2.67%
Cash From Operating Activities -$183.9K $359.8K $155.5K
YoY Change -32.25% 131.37% -140.53%
INVESTING ACTIVITIES
Capital Expenditures $86.30K $81.13K -$8.280K
YoY Change -197.32% -1079.78% -89.52%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$250.0K
YoY Change
Cash From Investing Activities -$86.30K -$81.13K -$258.3K
YoY Change -2.68% -68.59% 226.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 177.1K -$171.4K -919.9K
YoY Change -0.39% -81.36% -301.31%
NET CHANGE
Cash From Operating Activities -183.9K $359.8K 155.5K
Cash From Investing Activities -86.30K -$81.13K -258.3K
Cash From Financing Activities 177.1K -$171.4K -919.9K
Net Change In Cash -93.05K $107.2K -1.023M
YoY Change -48.95% -110.49% 17778.67%
FREE CASH FLOW
Cash From Operating Activities -$183.9K $359.8K $155.5K
Capital Expenditures $86.30K $81.13K -$8.280K
Free Cash Flow -$270.2K $278.7K $163.8K
YoY Change 47.85% 70.14% -153.77%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001068689
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 us-gaap Other Liability Current Related And Nonrelated Party Status Extensible Enumeration
OtherLiabilityCurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4 us-gaap Other Liability Current Related And Nonrelated Party Status Extensible Enumeration
OtherLiabilityCurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
usd
CY2023Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
usd
CY2022Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
usd
CY2023Q1 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
usd
CY2023Q1 ATDS Redemption Of Series B Preferred Stock
RedemptionOfSeriesBPreferredStock
usd
CY2023Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
usd
CY2022Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
CY2023Q1 ATDS Settlement Of Series B Preferred Stock Through Issuance Of Common Stock
SettlementOfSeriesBPreferredStockThroughIssuanceOfCommonStock
usd
CY2023Q1 ATDS Common Stock Issued In Conjunction With Convertible Note
CommonStockIssuedInConjunctionWithConvertibleNote
usd
CY2023Q1 ATDS Resolution Of Derivative Liability Upon Exercise Of Warrant
ResolutionOfDerivativeLiabilityUponExerciseOfWarrant
usd
CY2023Q1 ATDS Settlement Of Convertible Notes Payable Through Issuance Of Preferred Common Stock
SettlementOfConvertibleNotesPayableThroughIssuanceOfPreferredCommonStock
usd
CY2023Q1 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
usd
CY2023Q1 ATDS Finite Lived Intangible Assets Amortization Expense After Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearTwo
usd
CY2023Q1 ATDS Lessee Operating Lease Liability Payments Due After Year One
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearOne
usd
CY2023Q1 ATDS Finance Lease Liability Payments Due After Year One
FinanceLeaseLiabilityPaymentsDueAfterYearOne
usd
CY2023Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
usd
CY2023Q1 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
shares
CY2023Q1 ATDS Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
shares
CY2023Q1 ATDS Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
shares
CY2023Q1 ATDS Share Based Compensation Arrangements By Share Based Payment Award Non Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
shares
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
000-30542
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
DATA443 RISK MITIGATION, INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-0914051
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
4000 Sancar Way
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 400
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Research Triangle Park
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NC
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
27709
CY2023Q1 dei City Area Code
CityAreaCode
(919)
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
858-6542
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7775101 shares
CY2023Q1 us-gaap Cash
Cash
108956 usd
CY2022Q4 us-gaap Cash
Cash
1712 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
11080 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
31978 usd
CY2023Q1 ATDS Advance Payment For Acquisition
AdvancePaymentForAcquisition
2726188 usd
CY2022Q4 ATDS Advance Payment For Acquisition
AdvancePaymentForAcquisition
2726188 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
154192 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
91204 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
3000416 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
2851082 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
457819 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
427031 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
328762 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
405148 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
329664 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
454331 usd
CY2023Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
45673 usd
CY2022Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
45673 usd
CY2023Q1 us-gaap Assets
Assets
4162334 usd
CY2022Q4 us-gaap Assets
Assets
4183265 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1510966 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1031931 usd
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1584809 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1704249 usd
CY2023Q1 us-gaap Interest Payable Current
InterestPayableCurrent
710960 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
478712 usd
CY2023Q1 us-gaap Notes Payable Current
NotesPayableCurrent
2091879 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
918785 usd
CY2023Q1 ATDS Convertible Note Payable Current
ConvertibleNotePayableCurrent
4431260 usd
CY2022Q4 ATDS Convertible Note Payable Current
ConvertibleNotePayableCurrent
4134155 usd
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
151272 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
112062 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
429907 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
213831 usd
CY2023Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
10341 usd
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
10341 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
10921394 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8604066 usd
CY2023Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
1555652 usd
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
3104573 usd
CY2023Q1 ATDS Convertible Note Payable Non Current
ConvertibleNotePayableNonCurrent
97946 usd
CY2022Q4 ATDS Convertible Note Payable Non Current
ConvertibleNotePayableNonCurrent
97946 usd
CY2023Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
718145 usd
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
788902 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
30100 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
354631 usd
CY2023Q1 us-gaap Liabilities
Liabilities
13323237 usd
CY2022Q4 us-gaap Liabilities
Liabilities
12950118 usd
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
150 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
150 usd
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6746674 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6746674 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2615737 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2615737 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
6742 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
2611 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
42982226 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
42642514 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-52150021 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-51412128 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-9160903 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-8766853 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4162334 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4183265 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1379806 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
612516 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
208982 usd
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
199679 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
1170824 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
412837 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1400809 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
973562 usd
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
32174 usd
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
120395 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
1432983 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
1093957 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-262159 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-681120 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
475734 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
1094316 usd
CY2022Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-57883 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-475734 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1152199 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-737893 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1833319 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-737893 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1833319 usd
CY2022Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
104631 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-737893 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1937950 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-13.75
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4384911 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
133344 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-8766853 usd
CY2023Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
229989 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
113854 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-737893 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-9160903 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-9160903 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-4223235 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-4223235 usd
CY2022Q1 ATDS Cumulative Effect Adjustment From Adoption Value
CumulativeEffectAdjustmentFromAdoptionValue
-77643 usd
CY2022Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
27812 usd
CY2022Q1 ATDS Common Stock Issued In Conjunction With Convertible Notes
CommonStockIssuedInConjunctionWithConvertibleNotes
62493 usd
CY2022Q1 ATDS Adjustments To Additional Paid In Capital Resolution Of Derivative Liability Upon Exercise Of Warrants
AdjustmentsToAdditionalPaidInCapitalResolutionOfDerivativeLiabilityUponExerciseOfWarrants
57883 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-87685 usd
CY2022Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
104631 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1833319 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-6178325 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-6178325 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-737893 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1833319 usd
CY2022Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-57883 usd
CY2023Q1 us-gaap Employee Benefits And Share Based Compensation Noncash
EmployeeBenefitsAndShareBasedCompensationNoncash
113854 usd
CY2022Q1 us-gaap Employee Benefits And Share Based Compensation Noncash
EmployeeBenefitsAndShareBasedCompensationNoncash
-87685 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
175005 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
269877 usd
CY2023Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
337143 usd
CY2022Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
734191 usd
CY2023Q1 ATDS Right Of Use Asset Amortization
RightOfUseAssetAmortization
76386 usd
CY2022Q1 ATDS Right Of Use Asset Amortization
RightOfUseAssetAmortization
-7479 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-20898 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
197979 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
62988 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-43899 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
479035 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
97515 usd
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-108455 usd
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-190197 usd
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
1042647 usd
CY2023Q1 ATDS Increase Decrease In Accrued Interest
IncreaseDecreaseInAccruedInterest
257009 usd
CY2022Q1 ATDS Increase Decrease In Accrued Interest
IncreaseDecreaseInAccruedInterest
35962 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
359797 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
155512 usd
CY2022Q1 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
250000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
81126 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8280 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-81126 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-258280 usd
CY2023Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
489070 usd
CY2022Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
902000 usd
CY2023Q1 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-70286 usd
CY2022Q1 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-729506 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
75000 usd
CY2022Q1 ATDS Redemption Of Series B Preferred Stock
RedemptionOfSeriesBPreferredStock
487730 usd
CY2022Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
21872 usd
CY2023Q1 ATDS Proceed From Notes Payable
ProceedFromNotesPayable
80960 usd
CY2022Q1 ATDS Proceed From Notes Payable
ProceedFromNotesPayable
438860 usd
CY2023Q1 ATDS Repayment Of Notes Payable
RepaymentOfNotesPayable
710381 usd
CY2022Q1 ATDS Repayment Of Notes Payable
RepaymentOfNotesPayable
972853 usd
CY2023Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
44210 usd
CY2023Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
5000 usd
CY2022Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
123788 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-171427 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-919889 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
107244 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1022657 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1712 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1204933 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
108956 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
182276 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
5979456 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
344867 usd
CY2022Q1 ATDS Settlement Of Series B Preferred Stock Through Issuance Of Common Stock
SettlementOfSeriesBPreferredStockThroughIssuanceOfCommonStock
7 usd
CY2023Q1 us-gaap Notes Issued1
NotesIssued1
229989 usd
CY2022Q1 us-gaap Notes Issued1
NotesIssued1
27812 usd
CY2022Q1 ATDS Common Stock Issued In Conjunction With Convertible Note
CommonStockIssuedInConjunctionWithConvertibleNote
62493 usd
CY2022Q1 ATDS Resolution Of Derivative Liability Upon Exercise Of Warrant
ResolutionOfDerivativeLiabilityUponExerciseOfWarrant
57883 usd
CY2022Q1 ATDS Settlement Of Convertible Notes Payable Through Issuance Of Preferred Common Stock
SettlementOfConvertibleNotesPayableThroughIssuanceOfPreferredCommonStock
65600 usd
CY2022Q1 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
77643 usd
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023Q1 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
1998-05-04
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
124667 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
113854 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
87685 usd
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
151138508 shares
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
150051470 shares
CY2022Q1 ATDS Cumulative Effect Adjustment On Retained Earnings
CumulativeEffectAdjustmentOnRetainedEarnings
439857 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
954899 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
873773 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
497080 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
446742 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
457819 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
427031 usd
CY2023Q1 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
81126 usd
CY2022Q1 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
8280 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
5229851 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
5229851 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4900187 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4775520 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
329664 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
454331 usd
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
230272 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
286914 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
27000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
15750 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
329664 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
878744 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
427553 usd
CY2023Q1 ATDS Credit Cards
CreditCards
78855 usd
CY2022Q4 ATDS Credit Cards
CreditCards
50302 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
553367 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
554076 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1510966 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1031931 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
460007 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
121406 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
481774 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
75767 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
429907 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
30100 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2493151 usd
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1608596 usd
CY2023Q1 ATDS Contract With Customer Liability Deferral Of Revenue
ContractWithCustomerLiabilityDeferralOfRevenue
475769 usd
CY2022 ATDS Contract With Customer Liability Deferral Of Revenue
ContractWithCustomerLiabilityDeferralOfRevenue
3511678 usd
CY2023Q1 ATDS Contract With Customer Liability Recognition Of Deferred Revenue
ContractWithCustomerLiabilityRecognitionOfDeferredRevenue
-665966 usd
CY2022 ATDS Contract With Customer Liability Recognition Of Deferred Revenue
ContractWithCustomerLiabilityRecognitionOfDeferredRevenue
-2627123 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2302954 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2493151 usd
CY2023Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1584809 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1704249 usd
CY2023Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
718145 usd
CY2022Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
788902 usd
CY2023Q1 us-gaap Deferred Revenue
DeferredRevenue
2302954 usd
CY2022Q4 us-gaap Deferred Revenue
DeferredRevenue
2493151 usd
CY2023Q1 us-gaap Lessee Operating Lease Description
LesseeOperatingLeaseDescription
We have two noncancelable operating leases for office facilities, one that we entered into January 2019 and that expires January 10, 2024
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
76386 usd
CY2022Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
137813 usd
CY2023Q1 us-gaap Security Deposit
SecurityDeposit
33467 usd
CY2022Q4 us-gaap Security Deposit
SecurityDeposit
33467 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
360368 usd
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.08 pure
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y11M19D
CY2023Q1 us-gaap Lessee Finance Lease Term Of Contract1
LesseeFinanceLeaseTermOfContract1
P3Y
CY2023Q1 ATDS Capital Leases Annual Interest Rate
CapitalLeasesAnnualInterestRate
0.12 pure
CY2023Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
10341 usd
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
10341 usd
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
0 usd
CY2023Q1 ATDS Finance Lease Security Deposit
FinanceLeaseSecurityDeposit
0 usd
CY2022Q4 ATDS Finance Lease Security Deposit
FinanceLeaseSecurityDeposit
0 usd
CY2023Q1 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
10341 usd
CY2023Q1 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
10341 usd
CY2023Q1 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
5300 usd
CY2023Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
5041 usd
CY2023Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
10341 usd
CY2023Q1 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
267284 usd
CY2022Q4 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
267284 usd
CY2023Q1 us-gaap Finance Lease Right Of Use Asset Accumulated Amortization
FinanceLeaseRightOfUseAssetAccumulatedAmortization
267284 usd
CY2022Q4 us-gaap Finance Lease Right Of Use Asset Accumulated Amortization
FinanceLeaseRightOfUseAssetAccumulatedAmortization
258506 usd
CY2022Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
8778 usd
CY2023Q1 ATDS Convertible Notes Payable Gross
ConvertibleNotesPayableGross
4699300 usd
CY2022Q4 ATDS Convertible Notes Payable Gross
ConvertibleNotesPayableGross
4408786 usd
CY2023Q1 ATDS Debt Discount And Debt Issuance Cost
DebtDiscountAndDebtIssuanceCost
170094 usd
CY2022Q4 ATDS Debt Discount And Debt Issuance Cost
DebtDiscountAndDebtIssuanceCost
176685 usd
CY2023Q1 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
4529206 usd
CY2022Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
4232101 usd
CY2023Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
4431260 usd
CY2022Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
4134155 usd
CY2023Q1 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
97946 usd
CY2022Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
97946 usd
CY2022Q4 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.16 pure
CY2023Q1 us-gaap Derivative Instruments And Hedges Liabilities
DerivativeInstrumentsAndHedgesLiabilities
0 usd
CY2022Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-57883 usd
CY2022Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-57883 usd
CY2023Q1 ATDS Promissory Notes Payable Gross
PromissoryNotesPayableGross
4953557 usd
CY2022Q4 ATDS Promissory Notes Payable Gross
PromissoryNotesPayableGross
4400469 usd
CY2023Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
1306026 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
377111 usd
CY2023Q1 us-gaap Notes Payable
NotesPayable
3647531 usd
CY2022Q4 us-gaap Notes Payable
NotesPayable
4023358 usd
CY2023Q1 us-gaap Notes Payable Current
NotesPayableCurrent
2091879 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
918785 usd
CY2023Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
1555652 usd
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
3104573 usd
CY2023Q1 us-gaap Interest Expense Other
InterestExpenseOther
327736 usd
CY2022Q1 us-gaap Interest Expense Other
InterestExpenseOther
56457 usd
CY2023Q1 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
253430 usd
CY2022Q1 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
387766 usd
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
337500 shares
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
159974 shares
CY2022Q4 ATDS Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice
22.07
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
159974 shares
CY2023Q1 ATDS Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice
22.07
CY2023Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
0 shares
CY2023Q1 ATDS Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding And Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumber
159974 shares
CY2023Q1 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P3Y10M13D
CY2023Q1 ATDS Sharebased Compensation Shares Authorized Under Stock Non Option Plans Exercise Price Range Outstanding Non Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockNonOptionPlansExercisePriceRangeOutstandingNonOptionsWeightedAverageExercisePriceBeginningBalance1
22.07
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1088067 shares
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P8Y2M15D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
2.09
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
699840 shares
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P8Y11M4D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
2.43
CY2023Q1 ATDS Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVest
1088067 shares
CY2023Q1 ATDS Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestWeightedAverageRemainingContractualTerm1
P8Y2M15D
CY2023Q1 ATDS Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestWeightedAverageExercisePrice
2.09

Files In Submission

Name View Source Status
atds-20230331_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
0001493152-23-017327-index-headers.html Edgar Link pending
0001493152-23-017327-index.html Edgar Link pending
0001493152-23-017327.txt Edgar Link pending
0001493152-23-017327-xbrl.zip Edgar Link pending
atds-20230331.xsd Edgar Link pending
ex10-26.htm Edgar Link pending
ex10-27.htm Edgar Link pending
ex10-27_001.jpg Edgar Link pending
ex10-27_002.jpg Edgar Link pending
ex10-27_003.jpg Edgar Link pending
atds-20230331_def.xml Edgar Link unprocessable
atds-20230331_lab.xml Edgar Link unprocessable
atds-20230331_pre.xml Edgar Link unprocessable
ex10-27_004.jpg Edgar Link pending
ex10-27_005.jpg Edgar Link pending
ex10-27_006.jpg Edgar Link pending
ex10-27_007.jpg Edgar Link pending
ex10-27_008.jpg Edgar Link pending
ex10-27_009.jpg Edgar Link pending
ex10-27_010.jpg Edgar Link pending
ex10-27_011.jpg Edgar Link pending
ex10-27_012.jpg Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
ex4-21.htm Edgar Link pending
ex4-21_001.jpg Edgar Link pending
ex4-21_002.jpg Edgar Link pending
ex4-21_003.jpg Edgar Link pending
ex4-21_004.jpg Edgar Link pending
ex4-21_005.jpg Edgar Link pending
ex4-21_006.jpg Edgar Link pending
ex4-21_007.jpg Edgar Link pending
ex4-21_008.jpg Edgar Link pending
ex4-21_009.jpg Edgar Link pending
ex4-21_010.jpg Edgar Link pending
ex4-21_011.jpg Edgar Link pending
ex4-21_012.jpg Edgar Link pending
ex4-21_013.jpg Edgar Link pending
ex4-21_014.jpg Edgar Link pending
ex4-21_015.jpg Edgar Link pending
ex4-21_016.jpg Edgar Link pending
ex4-21_017.jpg Edgar Link pending
ex4-21_018.jpg Edgar Link pending
ex4-21_019.jpg Edgar Link pending
ex4-21_020.jpg Edgar Link pending
ex4-21_021.jpg Edgar Link pending
ex4-21_022.jpg Edgar Link pending
ex4-21_023.jpg Edgar Link pending
ex4-21_024.jpg Edgar Link pending
ex4-21_025.jpg Edgar Link pending
ex4-21_026.jpg Edgar Link pending
ex4-21_027.jpg Edgar Link pending
ex4-22.htm Edgar Link pending
ex4-22_001.jpg Edgar Link pending
ex4-22_002.jpg Edgar Link pending
ex4-22_003.jpg Edgar Link pending
ex4-22_004.jpg Edgar Link pending
ex4-22_005.jpg Edgar Link pending
ex4-22_006.jpg Edgar Link pending
ex4-22_007.jpg Edgar Link pending
ex4-22_008.jpg Edgar Link pending
ex4-22_009.jpg Edgar Link pending
ex4-22_010.jpg Edgar Link pending
ex4-22_011.jpg Edgar Link pending
ex4-22_012.jpg Edgar Link pending
ex4-23.htm Edgar Link pending
ex4-23_001.jpg Edgar Link pending
ex4-23_002.jpg Edgar Link pending
ex4-23_003.jpg Edgar Link pending
ex4-23_004.jpg Edgar Link pending
ex4-23_005.jpg Edgar Link pending
ex4-23_006.jpg Edgar Link pending
ex4-23_007.jpg Edgar Link pending
ex4-23_008.jpg Edgar Link pending
ex4-23_009.jpg Edgar Link pending
ex4-23_010.jpg Edgar Link pending
ex4-23_011.jpg Edgar Link pending
ex4-23_012.jpg Edgar Link pending
ex4-23_013.jpg Edgar Link pending
ex4-23_014.jpg Edgar Link pending
ex4-23_015.jpg Edgar Link pending
ex4-23_016.jpg Edgar Link pending
ex4-23_017.jpg Edgar Link pending
ex4-23_018.jpg Edgar Link pending
ex4-23_019.jpg Edgar Link pending
ex4-23_020.jpg Edgar Link pending
ex4-23_021.jpg Edgar Link pending
ex4-23_022.jpg Edgar Link pending
ex4-23_023.jpg Edgar Link pending
ex4-23_024.jpg Edgar Link pending
ex4-23_025.jpg Edgar Link pending
ex4-23_026.jpg Edgar Link pending
ex4-23_027.jpg Edgar Link pending
ex4-23_028.jpg Edgar Link pending
ex4-24.htm Edgar Link pending
ex4-24_001.jpg Edgar Link pending
ex4-24_002.jpg Edgar Link pending
ex4-24_003.jpg Edgar Link pending
ex4-24_004.jpg Edgar Link pending
ex4-24_005.jpg Edgar Link pending
ex4-24_006.jpg Edgar Link pending
ex4-24_007.jpg Edgar Link pending
ex4-24_008.jpg Edgar Link pending
ex4-24_009.jpg Edgar Link pending
ex4-24_010.jpg Edgar Link pending
ex4-24_011.jpg Edgar Link pending
ex4-24_012.jpg Edgar Link pending
ex4-24_013.jpg Edgar Link pending
ex4-24_014.jpg Edgar Link pending
ex4-24_015.jpg Edgar Link pending
ex4-24_016.jpg Edgar Link pending
ex4-24_017.jpg Edgar Link pending
ex4-24_018.jpg Edgar Link pending
ex4-24_019.jpg Edgar Link pending
ex4-24_020.jpg Edgar Link pending
ex4-24_021.jpg Edgar Link pending
ex4-24_022.jpg Edgar Link pending
ex4-24_023.jpg Edgar Link pending
ex4-24_024.jpg Edgar Link pending
ex4-24_025.jpg Edgar Link pending
ex4-24_026.jpg Edgar Link pending
ex4-24_027.jpg Edgar Link pending
ex4-24_028.jpg Edgar Link pending
ex4-24_029.jpg Edgar Link pending
ex4-24_030.jpg Edgar Link pending
ex4-24_031.jpg Edgar Link pending
ex4-24_032.jpg Edgar Link pending
ex4-24_033.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
form10-q_htm.xml Edgar Link completed
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending